Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention. RISK Study

NCT01889030 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01889030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01889030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention. RISK Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 31, 2013
Completion date
June 30, 2014
Enrollment
516 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular primary prevention